<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2005-08-30" modified="2020-10-07" version="158">
<accession>Q9HAW4</accession>
<accession>A6NFL4</accession>
<accession>Q1RMC6</accession>
<accession>Q2KHM3</accession>
<accession>Q5VYG0</accession>
<accession>Q6P6H5</accession>
<accession>Q8IWI1</accession>
<name>CLSPN_HUMAN</name>
<protein>
<recommendedName>
<fullName>Claspin</fullName>
<shortName>hClaspin</shortName>
</recommendedName>
</protein>
<gene>
<name type="primary">CLSPN</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2000" name="Mol. Cell" volume="6" first="839" last="849">
<title>Claspin, a novel protein required for the activation of Chk1 during a DNA replication checkpoint response in Xenopus egg extracts.</title>
<authorList>
<person name="Kumagai A."/>
<person name="Dunphy W.G."/>
</authorList>
<dbReference type="PubMed" id="11090622"/>
<dbReference type="DOI" id="10.1016/s1097-2765(05)00092-4"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
<title>The DNA sequence and biological annotation of human chromosome 1.</title>
<authorList>
<person name="Gregory S.G."/>
<person name="Barlow K.F."/>
<person name="McLay K.E."/>
<person name="Kaul R."/>
<person name="Swarbreck D."/>
<person name="Dunham A."/>
<person name="Scott C.E."/>
<person name="Howe K.L."/>
<person name="Woodfine K."/>
<person name="Spencer C.C.A."/>
<person name="Jones M.C."/>
<person name="Gillson C."/>
<person name="Searle S."/>
<person name="Zhou Y."/>
<person name="Kokocinski F."/>
<person name="McDonald L."/>
<person name="Evans R."/>
<person name="Phillips K."/>
<person name="Atkinson A."/>
<person name="Cooper R."/>
<person name="Jones C."/>
<person name="Hall R.E."/>
<person name="Andrews T.D."/>
<person name="Lloyd C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Anderson F."/>
<person name="Andrew R.W."/>
<person name="Ashwell R.I.S."/>
<person name="Aubin K."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Beasley H."/>
<person name="Bethel G."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown J.Y."/>
<person name="Brown A.J."/>
<person name="Buckley D."/>
<person name="Burton J."/>
<person name="Bye J."/>
<person name="Carder C."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Davies J."/>
<person name="Deadman R."/>
<person name="Dunn M."/>
<person name="Earthrowl M."/>
<person name="Ellington A.G."/>
<person name="Errington H."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gay L."/>
<person name="Ghori M.R.J."/>
<person name="Gibson R."/>
<person name="Gilby L.M."/>
<person name="Gillett W."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Hammond S."/>
<person name="Harrison E.S.I."/>
<person name="Hart E."/>
<person name="Haugen E."/>
<person name="Heath P.D."/>
<person name="Holmes S."/>
<person name="Holt K."/>
<person name="Howden P.J."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Hunter G."/>
<person name="Isherwood J."/>
<person name="James R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A."/>
<person name="Kay M."/>
<person name="Kershaw J.K."/>
<person name="Kibukawa M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A.J."/>
<person name="Lad H."/>
<person name="Laird G."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="Lush M.J."/>
<person name="Lyne R."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Matthews N.S.W."/>
<person name="McLaren S."/>
<person name="Milne S."/>
<person name="Mistry S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="O'Dell C.N."/>
<person name="Oliver K."/>
<person name="Palmeiri A."/>
<person name="Palmer S.A."/>
<person name="Parker A."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phelps K."/>
<person name="Phillimore B.J."/>
<person name="Plumb R."/>
<person name="Rajan J."/>
<person name="Raymond C."/>
<person name="Rouse G."/>
<person name="Saenphimmachak C."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C."/>
<person name="Subramanian S."/>
<person name="Sycamore N."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Van Helmond Z."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="White S."/>
<person name="Whitehead S.L."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams H."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wu Z."/>
<person name="Coulson A."/>
<person name="Vaudin M."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Wooster R."/>
<person name="Dunham I."/>
<person name="Carter N.P."/>
<person name="McVean G."/>
<person name="Ross M.T."/>
<person name="Harrow J."/>
<person name="Olson M.V."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="16710414"/>
<dbReference type="DOI" id="10.1038/nature04727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2)</scope>
<source>
<tissue>Skin</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="30057" last="30062">
<title>Human claspin is required for replication checkpoint control.</title>
<authorList>
<person name="Chini C.C.S."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="12766152"/>
<dbReference type="DOI" id="10.1074/jbc.m301136200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CHEK1; ATR AND RAD9A</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INDUCTION</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Cell Cycle" volume="3" first="941" last="945">
<title>ATR, claspin and the Rad9-Rad1-Hus1 complex regulate Chk1 and Cdc25A in the absence of DNA damage.</title>
<authorList>
<person name="Sorensen C.S."/>
<person name="Syljuasen R.G."/>
<person name="Lukas J."/>
<person name="Bartek J."/>
</authorList>
<dbReference type="PubMed" id="15190204"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="39289" last="39295">
<title>Human claspin is a ring-shaped DNA-binding protein with high affinity to branched DNA structures.</title>
<authorList>
<person name="Sar F."/>
<person name="Lindsey-Boltz L.A."/>
<person name="Subramanian D."/>
<person name="Croteau D.L."/>
<person name="Hutsell S.Q."/>
<person name="Griffith J.D."/>
<person name="Sancar A."/>
</authorList>
<dbReference type="PubMed" id="15226314"/>
<dbReference type="DOI" id="10.1074/jbc.m405793200"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Proc. Natl. Acad. Sci. U.S.A." volume="101" first="6484" last="6489">
<title>Human claspin works with BRCA1 to both positively and negatively regulate cell proliferation.</title>
<authorList>
<person name="Lin S.-Y."/>
<person name="Li K."/>
<person name="Stewart G.S."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="15096610"/>
<dbReference type="DOI" id="10.1073/pnas.0401847101"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH BRCA1</scope>
<scope>PHOSPHORYLATION BY ATR</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2005" name="Biochem. J." volume="388" first="705" last="712">
<title>DNA-dependent phosphorylation of Chk1 and claspin in a human cell-free system.</title>
<authorList>
<person name="Clarke C.A.L."/>
<person name="Clarke P.R."/>
</authorList>
<dbReference type="PubMed" id="15707391"/>
<dbReference type="DOI" id="10.1042/bj20041966"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CHEK1</scope>
<scope>MUTAGENESIS OF THR-916; SER-945 AND SER-982</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2006" name="Cell" volume="126" first="529" last="542">
<title>A role for the deubiquitinating enzyme USP28 in control of the DNA-damage response.</title>
<authorList>
<person name="Zhang D."/>
<person name="Zaugg K."/>
<person name="Mak T.W."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="16901786"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.06.039"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>DEUBIQUITINATION BY USP28</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="33276" last="33282">
<title>Repeated phosphopeptide motifs in human Claspin are phosphorylated by Chk1 and mediate Claspin function.</title>
<authorList>
<person name="Chini C.C."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="16963448"/>
<dbReference type="DOI" id="10.1074/jbc.m604373200"/>
</citation>
<scope>PHOSPHORYLATION AT THR-916 BY CHEK1</scope>
<scope>INTERACTION WITH CHEK1</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2007" name="J. Mol. Biol." volume="366" first="36" last="52">
<title>Mammalian TIMELESS and Tipin are evolutionarily conserved replication fork-associated factors.</title>
<authorList>
<person name="Gotter A.L."/>
<person name="Suppa C."/>
<person name="Emanuel B.S."/>
</authorList>
<dbReference type="PubMed" id="17141802"/>
<dbReference type="DOI" id="10.1016/j.jmb.2006.10.097"/>
</citation>
<scope>INTERACTION WITH TIMELESS</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2007" name="Science" volume="316" first="1160" last="1166">
<title>ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.</title>
<authorList>
<person name="Matsuoka S."/>
<person name="Ballif B.A."/>
<person name="Smogorzewska A."/>
<person name="McDonald E.R. III"/>
<person name="Hurov K.E."/>
<person name="Luo J."/>
<person name="Bakalarski C.E."/>
<person name="Zhao Z."/>
<person name="Solimini N."/>
<person name="Lerenthal Y."/>
<person name="Shiloh Y."/>
<person name="Gygi S.P."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="17525332"/>
<dbReference type="DOI" id="10.1126/science.1140321"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-833</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Embryonic kidney</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2008" name="Cell" volume="134" first="256" last="267">
<title>The Cdc14B-Cdh1-Plk1 axis controls the G2 DNA-damage-response checkpoint.</title>
<authorList>
<person name="Bassermann F."/>
<person name="Frescas D."/>
<person name="Guardavaccaro D."/>
<person name="Busino L."/>
<person name="Peschiaroli A."/>
<person name="Pagano M."/>
</authorList>
<dbReference type="PubMed" id="18662541"/>
<dbReference type="DOI" id="10.1016/j.cell.2008.05.043"/>
</citation>
<scope>UBIQUITINATION BY THE APC/C COMPLEX</scope>
<scope>DEUBIQUITINATION BY USP28</scope>
<scope>INTERACTION WITH FZR1</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65; SER-67; SER-225; SER-720; SER-808; SER-810; SER-846; SER-1012; SER-1018; SER-1020; SER-1156 AND SER-1289</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-839; SER-846; SER-1156 AND SER-1289</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-891</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65; SER-67; SER-225; SER-718; SER-723; SER-808; SER-810 AND SER-1289</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2011" name="Mol. Biol. Cell" volume="22" first="2834" last="2847">
<title>Role for casein kinase 1 in the phosphorylation of Claspin on critical residues necessary for the activation of Chk1.</title>
<authorList>
<person name="Meng Z."/>
<person name="Capalbo L."/>
<person name="Glover D.M."/>
<person name="Dunphy W.G."/>
</authorList>
<dbReference type="PubMed" id="21680713"/>
<dbReference type="DOI" id="10.1091/mbc.e11-01-0048"/>
</citation>
<scope>PHOSPHORYLATION BY CSNK1G1/CK1</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65; SER-67; SER-83 AND SER-225</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-83; SER-225; SER-260; SER-516; SER-718; SER-720; SER-731; SER-744; SER-762; SER-808; SER-810; SER-846; SER-950; SER-954; SER-958; SER-1156 AND SER-1289</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] ARG-439</scope>
</reference>
<comment type="function">
<text evidence="10 11 12 13 14">Required for checkpoint mediated cell cycle arrest in response to inhibition of DNA replication or to DNA damage induced by both ionizing and UV irradiation. Adapter protein which binds to BRCA1 and the checkpoint kinase CHEK1 and facilitates the ATR-dependent phosphorylation of both proteins. Can also bind specifically to branched DNA structures and may associate with S-phase chromatin following formation of the pre-replication complex (pre-RC). This may indicate a role for this protein as a sensor which monitors the integrity of DNA replication forks.</text>
</comment>
<comment type="subunit">
<text evidence="10 11 14 17 18 19">Interacts (phosphorylation-dependent) with CHEK1; regulates CLSPN function in checkpoint for DNA damage and replication. Interacts with ATR and RAD9A and these interactions are slightly reduced during checkpoint activation. Interacts with BRCA1 and this interaction increases during checkpoint activation. Interacts with TIMELESS.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1369377">
<id>Q9HAW4</id>
</interactant>
<interactant intactId="EBI-374969">
<id>O75419</id>
<label>CDC45</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1369377">
<id>Q9HAW4</id>
</interactant>
<interactant intactId="EBI-1383449">
<id>P50750</id>
<label>CDK9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1369377">
<id>Q9HAW4</id>
</interactant>
<interactant intactId="EBI-974488">
<id>O14757</id>
<label>CHEK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1369377">
<id>Q9HAW4</id>
</interactant>
<interactant intactId="EBI-724997">
<id>Q9UM11</id>
<label>FZR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="10">Nucleus</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q9HAW4-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q9HAW4-2</id>
<name>2</name>
<sequence type="described" ref="VSP_036033"/>
</isoform>
<isoform>
<id>Q9HAW4-3</id>
<name>3</name>
<sequence type="described" ref="VSP_036034"/>
</isoform>
</comment>
<comment type="induction">
<text evidence="10">Expression peaks at S/G2 phases of the cell cycle.</text>
</comment>
<comment type="domain">
<text>The C-terminus of the protein contains 3 potential CHEK1-binding motifs (CKB motifs). Potential phosphorylation sites within CKB motif 1 and CKB motif 2 are required for interaction with CHEK1.</text>
</comment>
<comment type="PTM">
<text evidence="10 11 17 20">Phosphorylated. Undergoes ATR-dependent phosphorylation by CHEK1 during activation of DNA replication or damage checkpoints. Phosphorylation by CSNK1G1/CK1 promotes CHEK1 binding.</text>
</comment>
<comment type="PTM">
<text evidence="15 19">Ubiquitinated by the anaphase promoting complex/cyclosome (APC/C) during G1 phase, leading to its degradation by the proteasome. Ubiquitination is mediated via its interaction with FZR1/CDH1. Following DNA damage, it is deubiquitinated by USP28 in G2 phase, preventing its degradation.</text>
</comment>
<comment type="similarity">
<text evidence="23">Belongs to the claspin family.</text>
</comment>
<comment type="sequence caution" evidence="23">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="AAH38991" version="1"/>
</conflict>
<text>Contaminating sequence. Potential poly-A sequence.</text>
</comment>
<comment type="sequence caution" evidence="23">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="AAH62215" version="1"/>
</conflict>
<text>Contaminating sequence. Potential poly-A sequence.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/CLSPNID40105ch1p34.html"/>
</comment>
<dbReference type="EMBL" id="AF297866">
<property type="protein sequence ID" value="AAG24515.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL354864">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC038991">
<property type="protein sequence ID" value="AAH38991.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC062215">
<property type="protein sequence ID" value="AAH62215.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC113116">
<property type="protein sequence ID" value="AAI13117.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC115025">
<property type="protein sequence ID" value="AAI15026.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC137279">
<property type="protein sequence ID" value="AAI37280.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC140789">
<property type="protein sequence ID" value="AAI40790.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS396.1">
<molecule id="Q9HAW4-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS53297.1">
<molecule id="Q9HAW4-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS81299.1">
<molecule id="Q9HAW4-3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001177410.1">
<molecule id="Q9HAW4-2"/>
<property type="nucleotide sequence ID" value="NM_001190481.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001317419.1">
<molecule id="Q9HAW4-3"/>
<property type="nucleotide sequence ID" value="NM_001330490.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_071394.2">
<molecule id="Q9HAW4-1"/>
<property type="nucleotide sequence ID" value="NM_022111.3"/>
</dbReference>
<dbReference type="SMR" id="Q9HAW4"/>
<dbReference type="BioGRID" id="122015">
<property type="interactions" value="48"/>
</dbReference>
<dbReference type="ELM" id="Q9HAW4"/>
<dbReference type="IntAct" id="Q9HAW4">
<property type="interactions" value="23"/>
</dbReference>
<dbReference type="MINT" id="Q9HAW4"/>
<dbReference type="STRING" id="9606.ENSP00000312995"/>
<dbReference type="iPTMnet" id="Q9HAW4"/>
<dbReference type="PhosphoSitePlus" id="Q9HAW4"/>
<dbReference type="BioMuta" id="CLSPN"/>
<dbReference type="DMDM" id="218512100"/>
<dbReference type="CPTAC" id="CPTAC-962"/>
<dbReference type="EPD" id="Q9HAW4"/>
<dbReference type="jPOST" id="Q9HAW4"/>
<dbReference type="MassIVE" id="Q9HAW4"/>
<dbReference type="MaxQB" id="Q9HAW4"/>
<dbReference type="PaxDb" id="Q9HAW4"/>
<dbReference type="PeptideAtlas" id="Q9HAW4"/>
<dbReference type="PRIDE" id="Q9HAW4"/>
<dbReference type="ProteomicsDB" id="81451">
<molecule id="Q9HAW4-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="81452">
<molecule id="Q9HAW4-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="81453">
<molecule id="Q9HAW4-3"/>
</dbReference>
<dbReference type="Antibodypedia" id="17335">
<property type="antibodies" value="92 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000251195">
<molecule id="Q9HAW4-3"/>
<property type="protein sequence ID" value="ENSP00000251195"/>
<property type="gene ID" value="ENSG00000092853"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000318121">
<molecule id="Q9HAW4-1"/>
<property type="protein sequence ID" value="ENSP00000312995"/>
<property type="gene ID" value="ENSG00000092853"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000373220">
<molecule id="Q9HAW4-2"/>
<property type="protein sequence ID" value="ENSP00000362317"/>
<property type="gene ID" value="ENSG00000092853"/>
</dbReference>
<dbReference type="GeneID" id="63967"/>
<dbReference type="KEGG" id="hsa:63967"/>
<dbReference type="UCSC" id="uc001bzi.4">
<molecule id="Q9HAW4-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="63967"/>
<dbReference type="DisGeNET" id="63967"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000092853.13"/>
<dbReference type="GeneCards" id="CLSPN"/>
<dbReference type="HGNC" id="HGNC:19715">
<property type="gene designation" value="CLSPN"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000092853">
<property type="expression patterns" value="Group enriched (bone marrow, lymphoid tissue, testis)"/>
</dbReference>
<dbReference type="MIM" id="605434">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9HAW4"/>
<dbReference type="OpenTargets" id="ENSG00000092853"/>
<dbReference type="PharmGKB" id="PA134920757"/>
<dbReference type="eggNOG" id="KOG4156">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000012738"/>
<dbReference type="InParanoid" id="Q9HAW4"/>
<dbReference type="OMA" id="QDIREVR"/>
<dbReference type="OrthoDB" id="132723at2759"/>
<dbReference type="PhylomeDB" id="Q9HAW4"/>
<dbReference type="TreeFam" id="TF328925"/>
<dbReference type="PathwayCommons" id="Q9HAW4"/>
<dbReference type="Reactome" id="R-HSA-111465">
<property type="pathway name" value="Apoptotic cleavage of cellular proteins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-176187">
<property type="pathway name" value="Activation of ATR in response to replication stress"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689880">
<property type="pathway name" value="Ub-specific processing proteases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693607">
<property type="pathway name" value="Processing of DNA double-strand break ends"/>
</dbReference>
<dbReference type="SIGNOR" id="Q9HAW4"/>
<dbReference type="BioGRID-ORCS" id="63967">
<property type="hits" value="537 hits in 875 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="CLSPN">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="CLSPN"/>
<dbReference type="GenomeRNAi" id="63967"/>
<dbReference type="Pharos" id="Q9HAW4">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q9HAW4"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="RNAct" id="Q9HAW4">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000092853">
<property type="expression patterns" value="Expressed in testis and 109 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q9HAW4">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q9HAW4">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0010997">
<property type="term" value="F:anaphase-promoting complex binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000217">
<property type="term" value="F:DNA secondary structure binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0032147">
<property type="term" value="P:activation of protein kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000077">
<property type="term" value="P:DNA damage checkpoint"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006281">
<property type="term" value="P:DNA repair"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0006260">
<property type="term" value="P:DNA replication"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000076">
<property type="term" value="P:DNA replication checkpoint"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0033314">
<property type="term" value="P:mitotic DNA replication checkpoint"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007095">
<property type="term" value="P:mitotic G2 DNA damage checkpoint"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0018105">
<property type="term" value="P:peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016579">
<property type="term" value="P:protein deubiquitination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="InterPro" id="IPR024146">
<property type="entry name" value="Claspin"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR14396">
<property type="entry name" value="PTHR14396"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0175">Coiled coil</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-0234">DNA repair</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Claspin" id="PRO_0000089875">
<location>
<begin position="1"/>
<end position="1339"/>
</location>
</feature>
<feature type="repeat" description="CKB motif 1">
<location>
<begin position="910"/>
<end position="919"/>
</location>
</feature>
<feature type="repeat" description="CKB motif 2">
<location>
<begin position="939"/>
<end position="948"/>
</location>
</feature>
<feature type="repeat" description="CKB motif 3">
<location>
<begin position="976"/>
<end position="985"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="9">
<location>
<begin position="162"/>
<end position="196"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="9">
<location>
<begin position="592"/>
<end position="681"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="26"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="42"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="46"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="53"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 5 6">
<location>
<position position="65"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 5 6">
<location>
<position position="67"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 7">
<location>
<position position="83"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="110"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="113"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 5 6 7">
<location>
<position position="225"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="260"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="516"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 7">
<location>
<position position="718"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 7">
<location>
<position position="720"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="723"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="731"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="744"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="762"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 5 7">
<location>
<position position="808"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 5 7">
<location>
<position position="810"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="833"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="839"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 4 7">
<location>
<position position="846"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="3">
<location>
<position position="891"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CHEK1" evidence="17">
<location>
<position position="916"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="950"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="954"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="958"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="1012"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="1018"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="1020"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 4 7">
<location>
<position position="1156"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 4 5 7">
<location>
<position position="1289"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_036033" evidence="22">
<location>
<begin position="527"/>
<end position="590"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_036034" evidence="21">
<original>VKKRGPSFMTSPSPKHLKTDDSTSGLTRSIFKYLES</original>
<variation>KIPEKDSDWLTWSGAPIPGFFRLSFDPHG</variation>
<location>
<begin position="1304"/>
<end position="1339"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast cancer sample; somatic mutation." id="VAR_035674" evidence="16">
<original>H</original>
<variation>R</variation>
<location>
<position position="439"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs7537203." id="VAR_023439">
<original>N</original>
<variation>S</variation>
<location>
<position position="525"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34390044." id="VAR_050867">
<original>P</original>
<variation>T</variation>
<location>
<position position="892"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35490896." id="VAR_050868">
<original>S</original>
<variation>L</variation>
<location>
<position position="1280"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs interaction with CHEK1." evidence="14">
<original>T</original>
<variation>A</variation>
<location>
<position position="916"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs interaction with CHEK1." evidence="14">
<original>S</original>
<variation>A</variation>
<location>
<position position="945"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with CHEK1." evidence="14">
<original>S</original>
<variation>A</variation>
<location>
<position position="982"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAI15026." ref="3" evidence="23">
<original>S</original>
<variation>G</variation>
<location>
<position position="34"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAI15026." ref="3" evidence="23">
<original>G</original>
<variation>E</variation>
<location>
<position position="446"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAG24515." ref="1" evidence="23">
<original>F</original>
<variation>S</variation>
<location>
<position position="628"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAG24515." ref="1" evidence="23">
<original>E</original>
<variation>G</variation>
<location>
<position position="664"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAG24515." ref="1" evidence="23">
<original>F</original>
<variation>S</variation>
<location>
<position position="738"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAI15026." ref="3" evidence="23">
<original>SDK</original>
<variation>GDE</variation>
<location>
<begin position="931"/>
<end position="933"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17525332"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q80YR7"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000255"/>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12766152"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15096610"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15190204"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15226314"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15707391"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16901786"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16963448"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17141802"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18662541"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21680713"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11090622"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000305"/>
<sequence length="1339" mass="151094" checksum="3F3E392D5915955F" modified="2008-12-16" version="3">MTGEVGSEVHLEINDPNVISQEEADSPSDSGQGSYETIGPLSEGDSDEEIFVSKKLKNRKVLQDSDSETEDTNASPEKTTYDSAEEENKENLYAGKNTKIKRIYKTVADSDESYMEKSLYQENLEAQVKPCLELSLQSGNSTDFTTDRKSSKKHIHDKEGTAGKAKVKSKRRLEKEERKMEKIRQLKKKETKNQEDDVEQPFNDSGCLLVDKDLFETGLEDENNSPLEDEESLESIRAAVKNKVKKHKKKEPSLESGVHSFEEGSELSKGTTRKERKAARLSKEALKQLHSETQRLIRESALNLPYHMPENKTIHDFFKRKPRPTCHGNAMALLKSSKYQSSHHKEIIDTANTTEMNSDHHSKGSEQTTGAENEVETNALPVVSKETQIITGSDESCRKDLVKNEELEIQEKQKQSDIRPSPGDSSVLQQESNFLGNNHSEECQVGGLVAFEPHALEGEGPQNPEETDEKVEEPEQQNKSSAVGPPEKVRRFTLDRLKQLGVDVSIKPRLGADEDSFVILEPETNRELEALKQRFWKHANPAAKPRAGQTVNVNVIVKDMGTDGKEELKADVVPVTLAPKKLDGASHTKPGEKLQVLKAKLQEAMKLRRFEERQKRQALFKLDNEDGFEEEEEEEEEMTDESEEDGEEKVEKEEKEEELEEEEEKEEEEEEEGNQETAEFLLSSEEIETKDEKEMDKENNDGSSEIGKAVGFLSVPKSLSSDSTLLLFKDSSSKMGYFPTEEKSETDENSGKQPSKLDEDDSCSLLTKESSHNSSFELIGSTIPSYQPCNRQTGRGTSFFPTAGGFRSPSPGLFRASLVSSASKSSGKLSEPSLPIEDSQDLYNASPEPKTLFLGAGDFQFCLEDDTQSQLLDADGFLNVRNHRNQYQALKPRLPLASMDENAMDANMDELLDLCTGKFTSQAEKHLPRKSDKKENMEELLNLCSGKFTSQDASTPASSELNKQEKESSMGDPMEEALALCSGSFPTDKEEEDEEEEFGDFRLVSNDNEFDSDEDEHSDSGNDLALEDHEDDDEEELLKRSEKLKRQMRLRKYLEDEAEVSGSDVGSEDEYDGEEIDEYEEDVIDEVLPSDEELQSQIKKIHMKTMLDDDKRQLRLYQERYLADGDLHSDGPGRMRKFRWKNIDDASQMDLFHRDSDDDQTEEQLDESEARWRKERIEREQWLRDMAQQGKITAEEEEEIGEDSQFMILAKKVTAKALQKNASRPMVIQESKSLLRNPFEAIRPGSAQQVKTGSLLNQPKAVLQKLAALSDHNPSAPRNSRNFVFHTLSPVKAEAAKESSKSQVKKRGPSFMTSPSPKHLKTDDSTSGLTRSIFKYLES</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

